Home

bizonyíték csepp Gabona median overall survival for diffuse astrocytoma Marad Pont Egyszerű

Risk factors for early progression of diffuse low-grade glioma in adults |  Chinese Neurosurgical Journal
Risk factors for early progression of diffuse low-grade glioma in adults | Chinese Neurosurgical Journal

IDH1/2 mutation is a prognostic marker for survival and predicts response  to chemotherapy for grade II gliomas concomitantly treated with radiation  therapy
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy

Glioma - Wikipedia
Glioma - Wikipedia

Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified...  | Download Scientific Diagram
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram

A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in  Patients with Diffuse Gliomas | American Journal of Neuroradiology
A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas | American Journal of Neuroradiology

Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2  Mutations in Human Cancer: Prognostic Implications for Gliomas
Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas

Kaplan-Meier overall survival of spinal cord astrocytoma by grade.... |  Download Scientific Diagram
Kaplan-Meier overall survival of spinal cord astrocytoma by grade.... | Download Scientific Diagram

Histopathological grading affects survival in patients with IDH-mutant  grade II and grade III diffuse gliomas - ScienceDirect
Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas - ScienceDirect

Population-based study on incidence, survival rates, and genetic  alterations of low-grade diffuse astrocytomas and oligodendrogliomas |  SpringerLink
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas | SpringerLink

Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... |  Download Scientific Diagram
Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram

Spotlights on adult patients with pediatric-type diffuse gliomas in  accordance with the 2021 WHO classification of CNS tumors - Frontiers
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors - Frontiers

Biomedicines | Free Full-Text | The Current State of Adult Glial Tumor  Patients’ Care in Kazakhstan: Challenges in Diagnosis and Patterns in  Survival Outcomes
Biomedicines | Free Full-Text | The Current State of Adult Glial Tumor Patients’ Care in Kazakhstan: Challenges in Diagnosis and Patterns in Survival Outcomes

IDH1/2 mutation is a prognostic marker for survival and predicts response  to chemotherapy for grade II gliomas concomitantly treated with radiation  therapy
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy

Astrocytoma Tumors – Symptoms, Diagnosis and Treatments
Astrocytoma Tumors – Symptoms, Diagnosis and Treatments

Current Oncology | Free Full-Text | Diagnostic Approaches to Adult-Type  Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study
Current Oncology | Free Full-Text | Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study

Predicting survival in anaplastic astrocytoma patients in a single-center  cohort of 108 patients | Radiation Oncology | Full Text
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text

Multidimensional scaling of diffuse gliomas: application to the 2016 World  Health Organization classification system with prognostically relevant  molecular subtype discovery | Acta Neuropathologica Communications | Full  Text
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery | Acta Neuropathologica Communications | Full Text

Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT‐NOW updates  for diffuse astrocytic tumors in adults. Working toward the extended use of  MRI data in integrated glioma diagnosis - Roux -
Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT‐NOW updates for diffuse astrocytic tumors in adults. Working toward the extended use of MRI data in integrated glioma diagnosis - Roux -

Advantages of gross total resection in patients with astrocytoma: A  population‑based study
Advantages of gross total resection in patients with astrocytoma: A population‑based study

Predicting overall survival in diffuse glioma from the presurgical  connectome | Scientific Reports
Predicting overall survival in diffuse glioma from the presurgical connectome | Scientific Reports

Overall survival of patients with diffuse astrocytomas. The presence of...  | Download Scientific Diagram
Overall survival of patients with diffuse astrocytomas. The presence of... | Download Scientific Diagram

Long-term follow-up in adult patients with low-grade glioma (WHO II)  postoperatively irradiated. Analysis of prognostic factors - ScienceDirect
Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors - ScienceDirect

Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic,  and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119  Issue 2 (2013) Journals
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals